fundmomentum.vc

Sanofi Ventures

France
Seed
Share

About Sanofi Ventures

Biotech, Digital Health, Immunology, Neurology, Rare Diseases, Vaccines - evergreen fund

Investment Focus

Location / RegionFrance
Funding StageSeed
Industry Focus
Biotech
Digital Health

Investor Signals Profile

active

Sweet Spot

Early-stage biotech or digital health with pharma M&A potential

immunology
rare diseases
neurology
vaccines
digital health

Bullish Signals

$625M new commitment, $1.4B AUMexternal
11 deals closed in 2025 alreadyexternal
3 exits, $3.25B combined in 2024external
Actively leading rounds vs. traditional VCsexternal
Sanofi pushing derm access — digital health signallinkedin
Derm access crisis — 16M French patients underservedlinkedin
Meningococcal vaccine expansion — infant indication EU approvedlinkedin

Contrarian Signals

Source is Sanofi, not a VC fundexternal
Strategic CVC — agenda tied to Sanofi pipelineexternal
Acquisition bias may limit founder independenceexternal
LinkedIn content brand-focused, low deal signallinkedin
Derm post PR-driven, no investment intent visiblelinkedin
Sports sponsorship content — ESG, not healthcare thesislinkedin
Special Olympics sponsorship — mission-washing, not core thesislinkedin

Founder Do's

Target immunology, neuro, rare disease, vaccines
Open to seed through crossover stage
Show clear M&A attractiveness to big pharma
Prepare strong clinical/preclinical data package
Ophthalmology also on radar

Founder Don'ts

Don't expect passive investor — they co-lead
Don't ignore strategic fit with Sanofi pipeline
Don't pitch without clear exit narrative

Key GPs & Partners

JH
Jason Hafler
Managing Director
lead-round focusedstrategic acquirer lensopportunistic

Unlock Investor Signals

$29/month for full signal access. Cancel anytime.

View PlansBrowse all Signal Profiles →

Fund Overview

Fund Size$625M
Saves0
Website
LinkedIn

Key People

Jason P. Hafler

Jason HaflerManaging Director

Related Funds

Jeito Capital II

€1B
France
Late Stage
Biotech, Therapeutics
Fund Manager:Jeito Capital
Late Stage
Biotech
Therapeutics

Don't Quit Ventures

$10M
France
Pre Seed
Fund Manager:Noa Khamallah
Pre Seed

Eiffel Impact Debt II

€777M
France
Pre Seed
Ai Ml
Fund Manager:Guillaume Anie
Pre Seed
Ai Ml